Evidence map›Paper›PMID 38285316›Full record

ArticleJournal of nephrology2024

Blood transfusion reactions and risk of acute kidney injury and major adverse kidney events.

Fidra Margarita De La Vega-Méndez, Miguel Ibarra Estrada, Esperanza Elizabeth Zuno-Reyes, Carmen Alejandra Gutierrez-Rivera, Ana Elisa Oliva-Martinez, Bladimir Díaz-Villavicencio, Clementina Elizabeth Calderon-Garcia, Jose David González-Barajas, Manuel Arizaga-Nápoles, Fernanda García-Peña and 11 more

Abstract read
In one paragraph

Article in Journal of nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Temporal Rule Mining for Enhanced Risk Pattern Extraction: A Case Study with Acute Kidney Injury.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2025
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Fidra Margarita De La Vega-MéndezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Miguel Ibarra EstradaIntensive Care Unit, Hospital Civil of Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
Esperanza Elizabeth Zuno-ReyesBlood Bank of the Hospital Civil of Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
Carmen Alejandra Gutierrez-RiveraBlood Bank of the Hospital Civil of Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
Ana Elisa Oliva-MartinezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Bladimir Díaz-VillavicencioNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Clementina Elizabeth Calderon-GarciaNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Jose David González-BarajasNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Manuel Arizaga-NápolesNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Fernanda García-PeñaUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico.
Gael Chávez-AlonsoUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico.
Adanari López-RiosBlood Bank of the Hospital Civil of Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
Juan Alberto Gomez-FregosoNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Francisco Gonzalo Rodriguez-GarciaNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Guillermo Navarro-BlackallerNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Ramón Medina-GonzálezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Luz Alcantar-VallinNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Guillermo García-GarcíaUniversity of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico.
Gabriela Jazmin Abundis-MoraNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Alejandro Martínez Gallardo-GonzálezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico.
Jonathan Samuel Chavez-IñiguezNephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Hospital 278, Colonia Centro, C.P. 44150, Guadalajara, Jalisco, Mexico. jonarchi_10@hotmail.com.ORCID 0000-0003-2786-6667

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood transfusion reactions may have a negative impact on organ function. It is unknown whether this association holds true for acute kidney injury (AKI). Therefore, we conducted a cohort study to assess the association between transfusion reactions and the incidence of AKI and major adverse kidney events.

methodsIn this retrospective cohort study, we included patients who received transfusion of blood products during hospitalization at the Hospital Civil of Guadalajara. We analyzed them according to the development of transfusion reactions, and the aim was to assess the association between transfusion reactions and AKI during long-term follow-up.

resultsFrom 2017 to 2021, 81,635 patients received a blood product transfusion, and 516 were included in our study. The most common transfusion was red blood cell packaging (50.4%), fresh frozen plasma (28.7%) and platelets (20.9%); of the 516 patients, 129 (25%) had transfusion reactions. Patients who had transfusion reactions were older and had more comorbidities. The most common type of transfusion reaction was allergic reaction (70.5%), followed by febrile nonhemolytic reaction (11.6%) and anaphylactoid reaction (8.5%). Most cases were considered mild. Acute kidney injury was more prevalent among those who had transfusion reactions (14.7%) than among those who did not (7.8%), p =  < 0.01; those with AKI had a higher frequency of diabetes, vasopressors, and insulin use. Transfusion reactions were independently associated with the development of AKI (RR 2.1, p =  < 0.02). Major adverse kidney events were more common in those with transfusion reactions. The mortality rate was similar between subgroups.

conclusionIn our retrospective cohort of patients who received blood product transfusions, 25% experienced transfusion reactions, and this event was associated with a twofold increase in the probability of developing AKI and some of the major adverse kidney events during long follow-up.

Indexed as

Acute Kidney InjuryBlood TransfusionTransfusion ReactionAdultFemaleHumansMaleMexicoMiddle AgedProbabilityRetrospective StudiesRiskYoung AdultAcute kidney injuryBlood transfusionsMajor adverse kidney eventsTransfusion reactions

Identifiers

PMID38285316
PMCPMC11239756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.